DB17382ExperimentalSmall molecule
AUM-601 is a highly selective pan-TRK(tropomyosin receptor kinase). It is currently being investigated in clinical trials for the treatment of cancer.
- Also known as
- CHC 2014 · HL 5101 · NOV 1601
- Code names
- AUM-601
Resolves to
Compound
Which companies are running trials of AUM-601, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account